This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 25 Apr 2022  |  North America

    US Health Insurance Growth Opportunities

    Transitional Care Delivery Models and Payer Policies Redefining Stakeholders’ Future Growth Strategies

    The United States is the world’s largest healthcare market, spending over 18% of its GDP on healthcare. Therefore, it is important for healthcare stakeholders to understand how the US healthcare market functions, primarily its insurance system. The US health insurance landscape has seen significant evolution through various legislations, ranging ...

    $2,450.00
  2. 22 Apr 2022  |  Global

    Global Deep Brain Stimulation Growth Opportunities

    Exploration of New Clinical Applications Drive Future Growth Potential

    Deep brain stimulation (DBS) therapies target a growing number of existing indications, including movement disorders and neuropsychiatric conditions, and newer areas such as lifestyle disorders, including diabetes and obesity. This will allow more patients to benefit from the therapy. According to the WHO, neurological diseases currently contribute...

    $2,450.00
  3. 18 Apr 2022  |  North America

    Global Vaccine Growth Opportunities

    Capability Expansion in Nucleic Acid-based Vaccines is Accelerating the Disruption in Vaccines Globally

    Frost & Sullivan provides an outlook for the global vaccine industry for 2022 and beyond, including emerging trends and growth opportunities. Innovation, which remains mainstream in vaccine development, is augmenting investments by emerging vaccine developers in designing novel technology platforms, especially for nucleic acid-based vaccines. Spurr...

    $4,950.00
  4. 13 Apr 2022  |  North America

    US Life Sciences Research Tools Growth Opportunities

    Transformational Growth with the Proposed Launch of ARPA-H to Spur Investments across High-risk, High-reward Translational Research Projects, Foster Breakthroughs, and Facilitate Equitable Access to Care

    The US life sciences research tools market encompasses analytical tools, instruments, consumables, reagents, and services (e.g., X-rays and sample preparation). Tools include laboratory automation and technologies that provide molecular insight into disease mechanisms and enable novel therapeutic and medical device development to improve human heal...

    $2,450.00
  5. 31 Mar 2022  |  North America

    US Ambulatory Surgery Centers Growth Opportunities

    Future Growth Potential of Ambulatory Surgery Centers Increases Opportunities for Medtech

    The shift of surgery volumes from inpatient to outpatient has been ongoing for a while, owing to lower costs. While several procedures are done in outpatient settings, public and private payers in the US push for ambulatory surgery centers (ASCs) to conduct these procedures in outpatient settings than in hospital outpatient departments (HOPDs), as ...

    $2,450.00
  6. 29 Mar 2022  |  Global

    Global Ultraviolet-C (UVC) Disinfectant Equipment Growth Opportunities

    Automated Robots are Empowering the Future Growth Of UVC Disinfectant Equipment

    The UVC disinfectant equipment market is expected to witness significant growth over the next 3-5 years, driven by the increased focus on infection control due to the COVID-19 pandemic, the expanding application areas, and the effectiveness of disinfection using UVC when compared to other methods. This Frost & Sullivan study provides information...

    $2,450.00
  7. 29 Mar 2022  |  North America

    US RCM Growth Opportunities

    Internal Challenges due to COVID-19 Accelerated the Shift to Revenue Cycle Management (RCM) Outsourcing

    This research service provides an overview of the US revenue cycle management, revenue forecast, and competitive analysis of various legacy and modular RCM solutions. This study explores RCM applications across front-end, middle, and back-end processes and the end users are hospitals and ambulatory physician practices. In addition, it offers detail...

    $4,950.00
  8. 08 Mar 2022  |  North America

    US Clinical Decision Support System (CDSS) Growth Opportunities

    Sparking Future Growth Potential for Health Data, AI, and SDoH to Increase Accuracy and Efficiency among Providers and Payers and Improve the Patient Journey

    Clinical decision support (CDS) is a broad concept with many definitions that are used variably, depending on the perspective and role of the expert. It includes a mix of evidence (content), analytics, workflow, devices, and software-based solutions that must include electronic health records (EHRs) and be maintained by an IT platform. This repo...

    $4,950.00
  9. 03 Mar 2022  |  Global

    Global Robot-assisted Surgical Devices (RASD) Growth Opportunities, 2021

    Regulatory Approvals, Reimbursement Policies, and Leasing Plans Support Healthcare Centers in Implementing Robotics Surgery

    Frost & Sullivan estimates the aging population and accompanying retirements to cause a significant physician shortfall of 55,000 to 150,000 by 2030, creating a gap in the healthcare system. Expanding the role of autonomous robots can mitigate the shortage. The healthcare sector is forecast to expand rapidly with the decentralization of institu...

    $4,950.00
  10. 03 Mar 2022  |  North America

    Global eClinical Solutions Growth Opportunities

    Decentralized Clinical Trials, Rising Mobile Health Adoption, and Cloud-based Platforms Lower Costs and Enhance Efficiency

    The COVID-19 pandemic impact on the biopharmaceutical industry has increased patient-centricity and the adoption of eClinical services digital platforms to manage clinical development programs. Capital investments and co-development recorded an uptick over the last 2 years, focusing on advancing clinical assets and expanding the number of Phase 2 a...

    $4,950.00